Biogen up as closely watched drug shows promise
January 08, 2015 at 08:38 AM EST
Biogen Idec's most-watched experimental therapy, known as anti-LINGO-1, showed promise in a mid-stage study in reversing the nerve damage associated with acute optic neuritis.
